Model Risk Scores May Underestimate Rate of Biochemical Recurrence in African American Men with Localized Prostate Cancer: A Cohort Analysis of Over 3000 Men

Author:

Reese Adam1,Epstein Matthew1,Syed Kaynaat2,Danella John3,Ginzburg Serge4ORCID,Belkoff Laurence5,Tomaszewski Jeffrey6,Trabulsi Edouard7ORCID,Singer Eric8,Jacobs Bruce9,Raman Jay10,Guzzo Thomas,Uzzo Robert

Affiliation:

1. Lewis Katz School of Medicine at Temple University

2. Health Care Improvement Foundation

3. Geisinger Health System

4. Einstein Healthcare Network

5. MidLantic Urology/Main Line Health

6. Cooper University Health Care

7. Sidney Kimmel Medical College, Thomas Jefferson University

8. Rutgers Cancer Institute of New Jersey

9. University of Pittsburgh Medical Center

10. The Pennsylvania State University, College of Medicine

Abstract

Abstract Introduction: This study aims to determine if there is a difference in the CAPRA and Kattan model-adjusted risk of biochemical recurrence (BCR) and/or adverse pathology between African American (AAM) and Caucasian men (CM) undergoing radical prostatectomy (RP). Methods: We identified men in the Pennsylvania Urologic Regional Collaborative (PURC) who underwent radical prostatectomy (RP). Cox proportional hazards regression models were used to compare the rate of BCR after RP between CM and AAM adjusting for the CAPRA, CAPRA-S, and pre- and post-operative Kattan model score. Logistic regression models were used to compare the rate of adverse pathology after RP between CM and AAM, adjusting for the same models. Results: The 2-year BCR free survival was lower in AAM (72.5%) compared to Caucasian men (CM) (79.0%), with a hazard ratio (HR) of 1.38 (95% CI 1.16-1.63, p<0.001). The rate of BCR was significantly greater in AAM compared to CM after adjustment for pre-op Kattan (HR 1.29; 95% CI 1.08-1.53; p=0.004), and post-op Kattan scores (HR 1.26; 95% CI 1.05-1.49; p<0.001). There was a trend towards higher BCR rates among AAM after adjustment for CAPRA (HR 1.13; 95% CI 0.95-1.35; p=0.17) and CAPRA-S (HR 1.11; 95% 0.93-1.32; p=0.25), which did not reach statistical significance. The overall rate of adverse pathology was similar between AAM (38.4%) and CM (37.8%) (OR 1.02; 95% CI 0.89-1.17; p=0.72) but was significantly greater in AAM compared to CM after adjusting for CAPRA (OR 1.28; 95% CI 1.10-1.50; p=0.001) and Kattan scores (OR 1.23; 95% CI 1.06-1.43; p=0.007). Conclusion: Our analysis from a large multicenter real world cohort provides further evidence that African American men may have a greater-than predicted rate of BCR and adverse pathology after RP than is currently predicted by CAPRA and Kattan models. Accordingly, AAM may benefit from more frequent use of adjuvant therapies.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3